Sphera Funds Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.93M | Buy |
|
|||||
|
2024
Q2 | – | Hold |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $6.93M | Buy |
|
|||||
|
2023
Q3 | $6.39M | Sell |
|
|||||
|
2023
Q2 | $7.6M | Buy |
|
|||||
|
2022
Q3 | – | Hold |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $4.04M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $3.5M | Sell |
|
|||||
|
2018
Q2 | $19.2M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $3.99M | Buy |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $4.39M | Buy |
|
|||||
|
2015
Q4 | $3.77M | Hold |
|
|||||
|
2015
Q3 | $3.21M | Buy |
|
|||||
|
2015
Q2 | $4.43M | Buy |
|